SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Landrum who wrote (764)4/21/1999 11:20:00 AM
From: Bill J. Duke  Respond to of 1906
 
I also saw the interview and thought that while Binder wasn't "riveting" he did seen very credible. I also thought that he responded relatively non-defensively when responding to fairly critical questioning. He did make the point that it was only one analyst making the downgrade and also gave me the appearance of long term confidence. Some of the pipeline drugs have enormous potential.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News